Ventris Medical Receives 510(k) Clearance for Amplify(R) Standalone Bone Graft Putty and Bone Graft Extender

NEWPORT BEACH, Calif., Sept. 13, 2022 -- (Healthcare Sales & Marketing Network) -- Ventris Medical, a privately held orthobiologics and tissue regeneration company, today announced that the United States Food and Drug Administration has granted 510(k) cle... Devices, Regenerative Medicine, FDA Ventris Medical, Synthetic Bone Graft, bone graft
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news